D3A.8 — Other benign neuroendocrine tumors
Is D3A.8 billable?
Yes — D3A.8 is billable for FY2027. D3A.8 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. D3A.8 may be submitted for encounters from October 1, 2026 through September 30, 2027.
D3A.8 at a glance
| Code | D3A.8 |
|---|---|
| Description | Other benign neuroendocrine tumors |
| Billable | Yes |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
Which MS-DRGs does D3A.8 group to?
D3A.8 sits in MDC 17 and helps define the logic of 3 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.
- 826Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with MCCsurgical
- 827Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with CCsurgical
- 828Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures without CC/MCCsurgical
Inclusion terms
Alternative wording in documentation that is classified to D3A.8.
- Neuroendocrine tumor NOS
Use additional code — inherited from D3A
Report an additional code alongside D3A.8 to fully describe the condition. D3A.8 is sequenced first.
- code to identify any associated endocrine syndrome, such as:
- carcinoid syndrome (E34.00)
Excludes2 — not included here — inherited from D3A
The conditions below are not part of D3A.8, but a patient may have both at the same time. When documentation supports it, D3A.8 and the excluded code may both be reported.
- benign pancreatic islet cell tumors (D13.7)
Code also — inherited from D3A
Two codes may be needed to describe the condition fully. Whether D3A.8 is sequenced first depends on the reason for the encounter.
- any associated multiple endocrine neoplasia [MEN] syndromes (E31.2-)
How long has D3A.8 existed?
D3A.8 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.